IBRX vs RSG · rev $51.2M vs P/E 36, rev $9.78B
Immunitybio Inc (IBRX) versus Republic Services Inc (RSG) — a side-by-side from cached financials, not a winner call.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Republic Services Inc (RSG) is a waste management company listed on US.
Latest reported IBRX revenue for 2026-06-30 was $51.2M. Net income was -$230.4M. Revenue was up 15.9% from 2026-03-31 to 2026-06-30. IBRX currently screens at market cap $7.88B.
Latest reported RSG revenue for 2026-06-30 was $9.78B. Net income was $1.09B. RSG currently screens at market cap $75.36B and trailing P/E 36.4.
IBRX currently screens at market cap $7.88B. RSG currently screens at market cap $75.36B and trailing P/E 36.4.
Not investment advice. Open the IBRX and RSG stock pages for the full models.
Not investment advice.